NICE Explains Its UK Funding Recommendation For Kymriah

 
• By Neena Brizmohun

The final appraisal document published today by the health technology assessment body NICE provides more insight into the health technology assessment body’s recent recommendation on Kymriah’s use in young people with leukemia.

3d illustration of T cells or cancer cells
NICE has explained why it backed Kymriah's use via the Cancer Drugs Fund • Source: Shutterstock

More from Archive

More from Pink Sheet